Javascript must be enabled to continue!
MR imaging of hepatocellular carcinoma: prospective intraindividual head-to-head comparison of the contrast agents gadoxetic acid and gadoteric acid
View through CrossRef
AbstractThe routine use of dynamic-contrast-enhanced MRI (DCE-MRI) of the liver using hepatocyte-specific contrast agent (HSCA) as the standard of care for the study of focal liver lesions is not widely accepted and opponents invoke the risk of a loss in near 100% specificity of extracellular contrast agents (ECA) and the need for prospective head-to-head comparative studies evaluating the diagnostic performance of both contrast agents. The Purpose of this prospective intraindividual study was to conduct a quantitative and qualitative head-to-head comparison of DCE-MRI using HSCA and ECA in patients with liver cirrhosis and HCC. Twenty-three patients with liver cirrhosis and proven HCC underwent two 3 T-MR examinations, one with ECA (gadoteric acid) and the other with HSCA (gadoxetic acid). Signal-to-noise ratio (SNR), contrast-to-noise ratio (CNR), wash-in, wash-out, image quality, artifacts, lesion conspicuity, and major imaging features of LI-RADS v2018 were evaluated. Wash-in and wash-out were significantly stronger with ECA compared to HSCA (P < 0.001 and 0.006, respectively). During the late arterial phase (LAP), CNR was significantly lower with ECA (P = 0.005), while SNR did not differ significantly (P = 0.39). In qualitative analysis, ECA produced a better overall image quality during the portal venous phase (PVP) and delayed phase (DP) compared to HSCA (P = 0.041 and 0.008), showed less artifacts in the LAP and PVP (P = 0.003 and 0.034) and a higher lesion conspicuity in the LAP and PVP (P = 0.004 and 0.037). There was no significant difference in overall image quality during the LAP (P = 1), in artifacts and lesion conspicuity during the DP (P = 0.078 and 0.073) or in the frequency of the three major LI-RADS v2018 imaging features. In conclusion, ECA provides superior contrast of HCC—especially hypervascular HCC lesions—in DCE-MR in terms of better perceptibility of early enhancement and a stronger washout.
Springer Science and Business Media LLC
Title: MR imaging of hepatocellular carcinoma: prospective intraindividual head-to-head comparison of the contrast agents gadoxetic acid and gadoteric acid
Description:
AbstractThe routine use of dynamic-contrast-enhanced MRI (DCE-MRI) of the liver using hepatocyte-specific contrast agent (HSCA) as the standard of care for the study of focal liver lesions is not widely accepted and opponents invoke the risk of a loss in near 100% specificity of extracellular contrast agents (ECA) and the need for prospective head-to-head comparative studies evaluating the diagnostic performance of both contrast agents.
The Purpose of this prospective intraindividual study was to conduct a quantitative and qualitative head-to-head comparison of DCE-MRI using HSCA and ECA in patients with liver cirrhosis and HCC.
Twenty-three patients with liver cirrhosis and proven HCC underwent two 3 T-MR examinations, one with ECA (gadoteric acid) and the other with HSCA (gadoxetic acid).
Signal-to-noise ratio (SNR), contrast-to-noise ratio (CNR), wash-in, wash-out, image quality, artifacts, lesion conspicuity, and major imaging features of LI-RADS v2018 were evaluated.
Wash-in and wash-out were significantly stronger with ECA compared to HSCA (P < 0.
001 and 0.
006, respectively).
During the late arterial phase (LAP), CNR was significantly lower with ECA (P = 0.
005), while SNR did not differ significantly (P = 0.
39).
In qualitative analysis, ECA produced a better overall image quality during the portal venous phase (PVP) and delayed phase (DP) compared to HSCA (P = 0.
041 and 0.
008), showed less artifacts in the LAP and PVP (P = 0.
003 and 0.
034) and a higher lesion conspicuity in the LAP and PVP (P = 0.
004 and 0.
037).
There was no significant difference in overall image quality during the LAP (P = 1), in artifacts and lesion conspicuity during the DP (P = 0.
078 and 0.
073) or in the frequency of the three major LI-RADS v2018 imaging features.
In conclusion, ECA provides superior contrast of HCC—especially hypervascular HCC lesions—in DCE-MR in terms of better perceptibility of early enhancement and a stronger washout.
Related Results
Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract
Introduction
Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...
Abstract 659: A novel manganese MRI contrast agent (PyC3A) for the evaluation of hepatic neoplasms
Abstract 659: A novel manganese MRI contrast agent (PyC3A) for the evaluation of hepatic neoplasms
Abstract
Introduction:
Magnetic resonance imaging (MRI) is routinely used to diagnosis hepatic neoplasms. However, Gadolinium (Gd) is contraindicated ...
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Abstarct
Introduction
Isolated brain hydatid disease (BHD) is an extremely rare form of echinococcosis. A prompt and timely diagnosis is a crucial step in disease management. This ...
Carcinoma ex Pleomorphic Adenoma: A Case Series and Literature Review
Carcinoma ex Pleomorphic Adenoma: A Case Series and Literature Review
Abstract
Introduction
Carcinoma ex pleomorphic adenoma (CXPA) is a rare malignant salivary gland tumor that can lead to severe complications and carries a risk of distant metastasi...
Insight into the impact of diabetes mellitus on the increased risk of hepatocellular carcinoma: mini-review
Insight into the impact of diabetes mellitus on the increased risk of hepatocellular carcinoma: mini-review
AbstractHepatocellular carcinoma is a multifactorial disease which is associated with a background of many causal risk factors. Diabetes mellitus however is one of the most common ...
Improved visualization of Liver Metastases Adjacent to Vessels using Hepatobiliary Phase Gadoxetic-acid-enhanced Single Shot Inversion-Recovery Gradient-Echo (IRGRE) MR Imaging
Improved visualization of Liver Metastases Adjacent to Vessels using Hepatobiliary Phase Gadoxetic-acid-enhanced Single Shot Inversion-Recovery Gradient-Echo (IRGRE) MR Imaging
Objectives: To quantitatively compare contrast differences between liver metastases and vessels on Hepatobiliary Phase (HP) gadoxetic-acid-enhanced 2-Dimensional (2D) single-shot I...
Long interval between HCV infection and development of hepatocellular carcinoma
Long interval between HCV infection and development of hepatocellular carcinoma
Abstract: A high prevalence of HCV infection has been reported in patients with hepatocellular carcinoma. The progression from acute transfusion‐associated hepatitis to hepatic ci...
Current Perspectives on Hepatocellular Carcinoma: Summary and Evidence-Based Recommendations
Current Perspectives on Hepatocellular Carcinoma: Summary and Evidence-Based Recommendations
When cancerous cells grow inside the liver's tissues, this is called primary liver cancer. Primary liver cancer is
different from metastatic cancer, which starts in another part of...

